CH503037A - Verfahren zur Herstellung von Pyrimidin-nucleosiden und -nucleotiden - Google Patents

Verfahren zur Herstellung von Pyrimidin-nucleosiden und -nucleotiden

Info

Publication number
CH503037A
CH503037A CH577370A CH577370A CH503037A CH 503037 A CH503037 A CH 503037A CH 577370 A CH577370 A CH 577370A CH 577370 A CH577370 A CH 577370A CH 503037 A CH503037 A CH 503037A
Authority
CH
Switzerland
Prior art keywords
pyrimidinone
hydroxy
tetrahydro
ribofuranosyl
formula
Prior art date
Application number
CH577370A
Other languages
German (de)
English (en)
Inventor
Raymond Hanze Arthur
Walter Camiener Gerald
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CH503037A publication Critical patent/CH503037A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH577370A 1967-01-30 1968-01-25 Verfahren zur Herstellung von Pyrimidin-nucleosiden und -nucleotiden CH503037A (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61233167A 1967-01-30 1967-01-30
US63660867A 1967-05-08 1967-05-08
US66522467A 1967-09-05 1967-09-05

Publications (1)

Publication Number Publication Date
CH503037A true CH503037A (de) 1971-02-15

Family

ID=27417076

Family Applications (2)

Application Number Title Priority Date Filing Date
CH577370A CH503037A (de) 1967-01-30 1968-01-25 Verfahren zur Herstellung von Pyrimidin-nucleosiden und -nucleotiden
CH113668A CH503038A (de) 1967-01-30 1968-01-25 Verfahren zur Herstellung von Pyrimidin-nucleosiden und -nucleotiden

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH113668A CH503038A (de) 1967-01-30 1968-01-25 Verfahren zur Herstellung von Pyrimidin-nucleosiden und -nucleotiden

Country Status (9)

Country Link
US (1) US3462416A (US07915450-20110329-C00059.png)
JP (1) JPS4819639B1 (US07915450-20110329-C00059.png)
BE (1) BE710090A (US07915450-20110329-C00059.png)
CH (2) CH503037A (US07915450-20110329-C00059.png)
DE (1) DE1695976C3 (US07915450-20110329-C00059.png)
FR (2) FR8380M (US07915450-20110329-C00059.png)
GB (1) GB1193531A (US07915450-20110329-C00059.png)
IL (1) IL29296A (US07915450-20110329-C00059.png)
NL (1) NL144486B (US07915450-20110329-C00059.png)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3894000A (en) * 1971-01-27 1975-07-08 Upjohn Co Ara-cytidine derivatives and process of preparation
US3960840A (en) * 1972-12-29 1976-06-01 University Of Illinois Foundaton Fluorescent derivatives of adenine-containing compounds
US3893998A (en) * 1973-02-22 1975-07-08 Univ Illinois Fluorescent derivatives of cytosine-containing compounds
US4017606A (en) * 1973-10-04 1977-04-12 The Upjohn Company Organic compounds and process
US4096324A (en) * 1975-07-07 1978-06-20 The Upjohn Company Cytidine nucleoside compound
US4058602A (en) * 1976-08-09 1977-11-15 The United States Of America As Represented By The Department Of Health, Education And Welfare Synthesis, structure, and antitumor activity of 5,6-dihydro-5-azacytidine
DE2841898A1 (de) * 1978-09-26 1980-04-03 Robugen Gmbh Antivirales mittel auf der basis von 5-niedrigalkyl-2'-desoxyuridin-5' -monophosphaten
GB2037289B (en) * 1978-10-31 1983-05-05 Katsunuma N Nucleoside derivatives and an antileukemial agent containing the same as an active ingredient
US4275057A (en) * 1980-01-28 1981-06-23 The United States Of America As Represented By The Department Of Health, Education And Welfare Seven-membered ring compounds as inhibitors of cytidine deaminase
US5527782A (en) * 1990-03-13 1996-06-18 Acic (Canada) Inc. 5-halo-2,3'-O-cyclocytidines
SE9701219D0 (sv) * 1997-04-04 1997-04-04 Astra Pharma Prod New compounds
US9283242B2 (en) 2013-01-22 2016-03-15 Massachusetts Institute Of Technology Uses of dihydro bases
WO2022008025A1 (en) * 2020-07-05 2022-01-13 Since & Technology Development Fund Authority 2-hydroxyiminopyrimidine nucleosides and derivitives and antiviral uses thereto

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328388A (en) * 1964-09-02 1967-06-27 Merck & Co Inc Arabinofuranosyl pyrimidines and methods of preparing same

Also Published As

Publication number Publication date
JPS4819639B1 (US07915450-20110329-C00059.png) 1973-06-14
BE710090A (US07915450-20110329-C00059.png) 1968-07-30
DE1695976A1 (de) 1971-05-19
DE1695976C3 (de) 1981-10-01
CH503038A (de) 1971-02-15
US3462416A (en) 1969-08-19
FR8380M (US07915450-20110329-C00059.png) 1971-03-01
FR1579502A (US07915450-20110329-C00059.png) 1969-08-29
DE1695976B2 (de) 1980-12-18
GB1193531A (en) 1970-06-03
IL29296A (en) 1971-08-25
NL6801191A (US07915450-20110329-C00059.png) 1968-07-31
NL144486B (nl) 1975-01-15

Similar Documents

Publication Publication Date Title
DE69720811T2 (de) L-Ribavirin und dessen Verwendung
DE3854297T2 (de) Nucleoside und nucleotide mit antiviraler, antitumoraler, antimetastatischer sowie immunstimulierender wirkung.
DE2510866C3 (de) 4'-epi-Adriamycin a - und ß -Anomer, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2220246A1 (de) 1,2,4 Tnazol Nukleoside
DE2627156A1 (de) Purinzuckerderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
CH503037A (de) Verfahren zur Herstellung von Pyrimidin-nucleosiden und -nucleotiden
DE2521197C2 (de) 1-(2-Deoxy-β-D-erythro-pentofuranosyl)-5,6-dihydro-5-methyl-s-triazin-2,4(1H,3H)-dion und Derivate
DE2639135C2 (de) 1-Alkylcarbamoyl-5-Fluoruracil-Derivate, ihre Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE3508356C2 (US07915450-20110329-C00059.png)
CH467277A (de) Verfahren zur Herstellung von Cobalticorrinoiden
WO1987000174A2 (fr) 1-o-phosphono-saccharides, leur procede de production et d'utilisation
EP0300960B1 (de) Neue pharmazeutische Präparate sowie neue Lactosylverbindungen und ihre Herstellung
DE68928127T2 (de) 2'-Methylidenpyrimidinnukleosidverbindungen, ihre Verwendung und Verfahren zu ihrer Herstellung
CH668598A5 (de) Antitumor-antibiotika.
DE2118636A1 (de) 3-Nucleotide von Lincomycin und deren Analogen, Verfahren zu ihrer Herstellung und ihre Verwendung in therapeutischen Präparaten
DE2817923C2 (de) Septacidinverbindungen und diese enthaltende Arzneimittel
CH636010A5 (en) Composition for the treatment of tumours
EP1372670B1 (de) Caloporosid-derivate, verfahren zu deren herstellung und deren verwendung
DE2803681C2 (US07915450-20110329-C00059.png)
DE2944084A1 (de) 3'-polyphosphate von pyrimidinnucleosiden oder von guanosin und deren salze sowie die verwendung dieser verbindungen zur behandlung von leukaemie
US4104461A (en) 2,2'-Anhydro-β-D-arabinofuranosyl-5-fluorocytosine
DE2601755C2 (de) Pseudoisocytidin und dessen Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1643521B2 (de) 4'-demethyl-epipodophyllotoxin-beta-d- glucosidderivate sowie ein verfahren zu ihrer herstellung und arzneimittel mit einem gehalt dieser verbindungen
DE69310721T2 (de) Zuckerderivate von makroliden
DE2529533A1 (de) 3-desazaguanin sowie derivate dieser verbindung

Legal Events

Date Code Title Description
PL Patent ceased